BioLineRx Short Term Investments from 2010 to 2025

BLRX Stock

USD 0.10 0.02 16.67%

BioLineRx Short Term Investments yearly trend continues to be fairly stable with very little volatility. Short Term Investments will likely drop to about 28.6 M in 2025. During the period from 2010 to 2025, BioLineRx Short Term Investments regression line of annual values had r-squared of 0.33 and arithmetic mean of 27,329,516. View All Fundamentals

Short Term Investments

First Reported

2010-12-31

Previous Quarter

30.4 M

Current Value

20.3 M

Quarterly Volatility

12.9 M

Credit Downgrade

Yuan Drop

Covid

Check BioLineRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLineRx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 2.6 M or Selling General Administrative of 20.1 M, as well as many indicators such as Price To Sales Ratio of 10.09, Dividend Yield of 0.0 or PTB Ratio of 7.44. BioLineRx financial statements analysis is a perfect complement when working with BioLineRx Valuation or Volatility modules.

Check out the analysis of BioLineRx Correlation against competitors.

For more information on how to buy BioLineRx Stock please use our How to Invest in BioLineRx guide.

Latest BioLineRx's Short Term Investments Growth Pattern

Below is the plot of the Short Term Investments of BioLineRx over the last few years. Short Term Investments is an item under the current assets section of BioLineRx balance sheet. It contains any investments BioLineRx undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that BioLineRx can easily liquidate in the marketplace. It is BioLineRx's Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLineRx's overall financial position and show how it may be relating to other accounts over time.

Short Term Investments

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Short Term Investments

Timeline

BioLineRx Short Term Investments Regression Statistics

	Arithmetic Mean	27,329,516
	Geometric Mean	21,508,270
	Coefficient Of Variation	54.39
	Mean Deviation	12,383,969
	Median	28,853,626
	Standard Deviation	14,865,159
	Sample Variance	221T
	Range	41.5M
	R-Value	0.57
	Mean Square Error	159.5T
	R-Squared	0.33
	Significance	0.02
	Slope	1,783,888
	Total Sum of Squares	3314.6T

BioLineRx Short Term Investments History

	2025	28.6 M
	2024	44.5 M
	2023	38.7 M
	2022	40.5 M
	2021	44.1 M
	2020	5.8 M
	2019	22.2 M

Other Fundumenentals of BioLineRx

Cash And Short Term Investments

BioLineRx Short Term Investments component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Net Receivables	Total Current Assets	Short Term Debt	Net Tangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Capital Surpluse
Total Assets		0.53	0.6	0.78	0.76	0.49	0.75	0.69	0.65	0.71	0.57	-0.79	0.01	0.86	0.65	0.67	0.62	-0.11	-0.3	0.65	-0.19	-0.19
Total Stockholder Equity	0.53		-0.3	0.14	0.51	-0.45	0.24	-0.16	0.33	-0.03	-0.11	0.02	-0.06	0.52	-0.2	0.49	-0.2	0.68	0.46	-0.19	0.38	0.38
Accounts Payable	0.6	-0.3		0.75	0.39	0.96	0.59	0.9	0.47	0.8	0.76	-0.88	0.03	0.45	0.91	0.24	0.89	-0.67	-0.73	0.89	-0.71	-0.71
Long Term Debt	0.78	0.14	0.75		0.45	0.7	0.85	0.8	0.45	0.79	0.7	-0.86	0.15	0.52	0.82	0.3	0.79	-0.23	-0.52	0.77	-0.42	-0.42
Short Term Investments	0.76	0.51	0.39	0.45		0.28	0.29	0.49	0.52	0.55	0.55	-0.54	-0.13	0.95	0.29	0.94	0.25	0.03	0.01	0.47	-0.16	-0.16
Total Liab	0.49	-0.45	0.96	0.7	0.28		0.49	0.92	0.32	0.81	0.73	-0.83	0.04	0.36	0.89	0.17	0.87	-0.75	-0.74	0.91	-0.75	-0.75
Intangible Assets	0.75	0.24	0.59	0.85	0.29	0.49		0.54	0.61	0.47	0.52	-0.78	0.1	0.35	0.74	0.12	0.74	-0.27	-0.63	0.49	-0.1	-0.1
Common Stock	0.69	-0.16	0.9	0.8	0.49	0.92	0.54		0.32	0.96	0.66	-0.9	-0.08	0.61	0.88	0.42	0.84	-0.48	-0.51	1.0	-0.67	-0.67
Property Plant Equipment	0.65	0.33	0.47	0.45	0.52	0.32	0.61	0.32		0.22	0.56	-0.57	-0.14	0.47	0.51	0.34	0.52	-0.31	-0.52	0.27	-0.11	-0.11
Current Deferred Revenue	0.71	-0.03	0.8	0.79	0.55	0.81	0.47	0.96	0.22		0.59	-0.82	-0.05	0.69	0.78	0.52	0.73	-0.26	-0.3	0.97	-0.61	-0.61
Net Debt	0.57	-0.11	0.76	0.7	0.55	0.73	0.52	0.66	0.56	0.59		-0.71	0.24	0.45	0.65	0.34	0.62	-0.52	-0.65	0.64	-0.53	-0.53
Retained Earnings	-0.79	0.02	-0.88	-0.86	-0.54	-0.83	-0.78	-0.9	-0.57	-0.82	-0.71		0.13	-0.61	-0.92	-0.44	-0.89	0.51	0.65	-0.87	0.44	0.44
Net Receivables	0.01	-0.06	0.03	0.15	-0.13	0.04	0.1	-0.08	-0.14	-0.05	0.24	0.13		-0.15	-0.14	-0.19	-0.16	-0.04	-0.11	-0.07	0.07	0.07
Total Current Assets	0.86	0.52	0.45	0.52	0.95	0.36	0.35	0.61	0.47	0.69	0.45	-0.61	-0.15		0.4	0.93	0.36	0.03	0.02	0.6	-0.22	-0.22
Short Term Debt	0.65	-0.2	0.91	0.82	0.29	0.89	0.74	0.88	0.51	0.78	0.65	-0.92	-0.14	0.4		0.15	0.99	-0.61	-0.77	0.87	-0.59	-0.59
Net Tangible Assets	0.67	0.49	0.24	0.3	0.94	0.17	0.12	0.42	0.34	0.52	0.34	-0.44	-0.19	0.93	0.15		0.1	0.12	0.2	0.42	-0.03	-0.03
Short Long Term Debt	0.62	-0.2	0.89	0.79	0.25	0.87	0.74	0.84	0.52	0.73	0.62	-0.89	-0.16	0.36	0.99	0.1		-0.62	-0.79	0.82	-0.57	-0.57
Net Invested Capital	-0.11	0.68	-0.67	-0.23	0.03	-0.75	-0.27	-0.48	-0.31	-0.26	-0.52	0.51	-0.04	0.03	-0.61	0.12	-0.62		0.88	-0.47	0.42	0.42
Net Working Capital	-0.3	0.46	-0.73	-0.52	0.01	-0.74	-0.63	-0.51	-0.52	-0.3	-0.65	0.65	-0.11	0.02	-0.77	0.2	-0.79	0.88		-0.48	0.38	0.38
Capital Stock	0.65	-0.19	0.89	0.77	0.47	0.91	0.49	1.0	0.27	0.97	0.64	-0.87	-0.07	0.6	0.87	0.42	0.82	-0.47	-0.48		-0.69	-0.69
Long Term Debt Total	-0.19	0.38	-0.71	-0.42	-0.16	-0.75	-0.1	-0.67	-0.11	-0.61	-0.53	0.44	0.07	-0.22	-0.59	-0.03	-0.57	0.42	0.38	-0.69		1.0
Capital Surpluse	-0.19	0.38	-0.71	-0.42	-0.16	-0.75	-0.1	-0.67	-0.11	-0.61	-0.53	0.44	0.07	-0.22	-0.59	-0.03	-0.57	0.42	0.38	-0.69	1.0

Click cells to compare fundamentals

About BioLineRx Financial Statements

BioLineRx investors use historical fundamental indicators, such as BioLineRx's Short Term Investments, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioLineRx. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Short Term Investments	44.5 M	28.6 M
Cash And Short Term Investments	49.4 M	39.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for BioLineRx Stock Analysis

When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioLineRx Short Term Investments from 2010 to 2025

Latest BioLineRx's Short Term Investments Growth Pattern

BioLineRx Short Term Investments Regression Statistics

BioLineRx Short Term Investments History

Other Fundumenentals of BioLineRx

BioLineRx Short Term Investments component correlations

About BioLineRx Financial Statements

Also Currently Popular

Additional Tools for BioLineRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY